World's Best Scientists 2026 revealed!
Jerald C. Sadoff

Jerald C. Sadoff

Award Badge
Immunology
Belgium
2026

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 92 1001 911 8 8 271 34323
Medicine 92 11225 10550 135 130 273 34344

Jerald C. Sadoff publications per year

The chart shows the history of publications by Jerald C. Sadoff between 1974 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jerald C. Sadoff published across 52 years, from 1974 to 2025, averaging 5.8 papers a year. Output peaked at 17 publications in 2021. 15 of the 301 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1974 to 2025. Vertical axis: number of publications, 0 to 17. Peak 17 publications in 2021. 1974: 3 publications 1975: 0 publications 1976: 0 publications 1977: 4 publications 1978: 4 publications 1979: 3 publications 1980: 4 publications 1981: 5 publications 1982: 3 publications 1983: 2 publications 1984: 6 publications 1985: 5 publications 1986: 6 publications 1987: 5 publications 1988: 10 publications 1989: 11 publications 1990: 8 publications 1991: 11 publications 1992: 5 publications 1993: 11 publications 1994: 13 publications 1995: 16 publications 1996: 15 publications 1997: 8 publications 1998: 2 publications 1999: 1 publication 2000: 2 publications 2001: 1 publication 2002: 3 publications 2003: 1 publication 2004: 0 publications 2005: 10 publications 2006: 3 publications 2007: 8 publications 2008: 9 publications 2009: 4 publications 2010: 9 publications 2011: 3 publications 2012: 2 publications 2013: 2 publications 2014: 6 publications 2015: 6 publications 2016: 3 publications 2017: 2 publications 2018: 2 publications 2019: 2 publications 2020: 4 publications 2021: 17 publications 2022: 15 publications 2023: 11 publications 2024: 11 publications 2025: 4 publications
1974 2025

301 publications in total across all disciplines

View publications per year as a table
Jerald C. Sadoff: publications per year, 1974 to 2025
Year Publications
1974 3
1975 0
1976 0
1977 4
1978 4
1979 3
1980 4
1981 5
1982 3
1983 2
1984 6
1985 5
1986 6
1987 5
1988 10
1989 11
1990 8
1991 11
1992 5
1993 11
1994 13
1995 16
1996 15
1997 8
1998 2
1999 1
2000 2
2001 1
2002 3
2003 1
2004 0
2005 10
2006 3
2007 8
2008 9
2009 4
2010 9
2011 3
2012 2
2013 2
2014 6
2015 6
2016 3
2017 2
2018 2
2019 2
2020 4
2021 17
2022 15
2023 11
2024 11
2025 4
Total 301
Download as CSV

Jerald C. Sadoff publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jerald C. Sadoff sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 262–271 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 271 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116 271
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Jerald C. Sadoff D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jerald C. Sadoff sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 92–93 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 92 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72 92
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Immunology in Belgium Leader Award
  • 2025 - Research.com Immunology in Belgium Leader Award

Overview

Jerald C. Sadoff is affiliated with Janssen in Belgium and has an extensive research profile primarily in the field of Medicine. Their work focuses significantly on Infectious Diseases, with notable contributions to Epidemiology, Immunology, Molecular Biology, and Genetics as subfields of study.

The main topics central to their research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Respiratory viral infections research
  • Vaccines and immunoinformatics approaches
  • Virus-based gene therapy research
  • Influenza Virus Research Studies
  • Vaccine Coverage and Hesitancy

Jerald C. Sadoff has contributed to several peer-reviewed journals and publication venues, frequently appearing in the following:

  • New England Journal of Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccine
  • Open Forum Infectious Diseases
  • UNC Libraries

Some of their recent papers include:

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19, 2021, New England Journal of Medicine
  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine, 2021, New England Journal of Medicine
  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans, 2021, Nature
  • Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19, 2021, JAMA
  • Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination, 2021, New England Journal of Medicine

In terms of collaboration, Jerald C. Sadoff frequently co-authors with several researchers including:

  • Mathieu Le Gars
  • Macaya Douoguih
  • Hanneke Schuitemaker
  • Frank Struyf
  • Carla Truyers

Best Publications

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

    Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas

  • Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

    Ziegler Ej;Fisher Cj;Sprung Cl;Straube Rc

  • Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein

    Charles J. Fisher;Jan M. Agosti;Steven M. Opal;Stephen F. Lowry

  • Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

    Fisher Cj;Dhainaut Jf;Opal Sm;Pribble Jp

  • Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli

    Ziegler Ej;McCutchan Ja;Fierer J;Glauser Mp

  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.

    Jerald Sadoff;Mathieu Le Gars;Georgi Shukarev;Dirk Heerwegh

  • Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

    Steven M. Opal;Charles J. Fisher;Jean-Francois A. Dhainaut;Jean-Louis Vincent

  • Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis

    Charles J. Fisher;S.M. Opal;Jean-Francois Dhainaut;S Stephens

  • Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

    Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield

  • Attenuated Shigella as a DNA Delivery Vehicle for DNA-Mediated Immunization

    Donata R. Sizemore;Arthur A. Branstrom;Jerald C. Sadoff

  • Advances in tuberculosis vaccine strategies.

    Yasir A. W. Skeiky;Jerald C. Sadoff

  • Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.

    D. M. Gordon;T. W. McGovern;U. Krzych;J. C. Cohen

  • Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.

    JC Sadoff;WR Ballou;LS Baron;WR Majarian

  • Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

    Unknown

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh

  • Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.

    Terhi Kilpi;Heidi Åhman;Jukka Jokinen;Kari S. Lankinen

  • Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

    Dani Cohen;Dani Cohen;Shai Ashkenazi;Shai Ashkenazi;Manfred S Green;Manfred S Green;Michael Gdalevich

  • The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.

    Kwang Sik Kim;Hideo Itabashi;Peter Gemski;Jerald Sadoff

  • Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.

    A S Cross;J C Sadoff;N Kelly;E Bernton

  • Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

    Christian F. Ockenhouse;Pei Fang Sun;David E. Lanar;Bruce T. Wellde

  • Use of Azithromycin for the Treatment of Campylobacter Enteritis in Travelers to Thailand, an Area Where Ciprofloxacin Resistance Is Prevalent

    Robert A. Kuschner;Andrew F. Trofa;Richard J. Thomas;Charles W. Hoge

  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.

    Galit Alter;Galit Alter;Jingyou Yu;Jinyan Liu;Abishek Chandrashekar

Frequent Co-Authors

Alan S. Cross
Alan S. Cross University of Maryland, Baltimore
Stanley J. Cryz
Stanley J. Cryz University of Massachusetts Chan Medical School
David N. Taylor
David N. Taylor Johns Hopkins University
Steven M. Opal
Steven M. Opal Brown University
Barbara H. Iglewski
Barbara H. Iglewski University of Rochester
Dan H. Barouch
Dan H. Barouch Harvard Medical School
Hanneke Schuitemaker
Hanneke Schuitemaker Valneva (Austria)
Willem A. Hanekom
Willem A. Hanekom University College London
Jaap Goudsmit
Jaap Goudsmit Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Programs like Licensed Practical Nurse (LPN) paths often serve as entry points into the medical field, and those looking for less stringent admissions may find the lpn programs with easiest admission requirements particularly appealing. These programs provide foundational patient care skills that complement immunological knowledge.

Advancing further, many pursue Nurse Practitioner degrees that combine clinical expertise with specialized practice. The easiest nurse practitioner program options can help professionals transition smoothly, balancing coursework and practical experience.

Specialties such as psychiatric mental health nurse practitioner (PMHNP) programs integrate immunological studies with mental health, often featuring robust clinical placement opportunities. Interested students should consider the best pmhnp programs to maximize hands-on experience and career readiness.

Cost is also crucial when selecting a program. Fortunately, several affordable options exist, and exploring the cheapest psych np programs can reduce financial barriers while ensuring quality education in psychiatric nursing aligned with immunological principles.

Best Scientists Citing Jerald C. Sadoff

Trending Scientists

Recently Published Articles